23andMe Jumps into Telehealth with New M&A

With its latest proposed acquisition, 23andMe could get into one of the fastest growing markets in healthcare – telemedicine.

The consumer genetics company said it signed a definitive agreement to acquire Lemonaid Health, an on-demand platform for accessing medical care and pharmacy services online, for $400 million.